Clinical Implications of Expression of EphA2 and PRMT1 in Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Zhang, Sheng [1 ]
Qiu, Rui [1 ]
Lv, Zhiping [1 ]
Yang, Liying [1 ]
He, Wei [1 ]
机构：
[1] Ningxia Med Univ, Gen Hosp, Gen Thorac Surg, 804 Shengli St, Yinchuan 750003, Ningxia Hui Aut, Peoples R China
来源：
PAKISTAN JOURNAL OF ZOOLOGY | 2024年 / 56卷 / 03期
关键词：
Key Non-small cell lung cancer; EphA2; PRMT1;
D O I：
10.17582/journal.pjz/20230424070439
中图分类号：
Q95 [动物学];
学科分类号：
071002 ;
摘要：
This study aims to investigate the relationship between EphA2 level and PRMT1 expression in non-small cell lung cancer patients (NSCLCP). This a retrospective observational study totally includes 40 participants, and these participants are divided into following two groups: control group (health participants), experimental group (NSCLCP), and then all these participants receive standardized bronchoalveolar lavage. Participants' general data are collected and analyzed. EphA2 expression and PRMT1 expression in blood samples are determined by ELISA, and EphA2 protein and PRMT1 protein in bronchoalveolar lavage fluid (BALF) samples are determined by western blotting, and then EphA2 mRNA and PRMT1 mRNA in BALF samples are determined by RT-PCR. The EphA2 expression and PRMT1 expression in experimental group were found clearly higher than those in the control. It appears up-regulation of EphA2 and PRMT1 expression can promote the development of NSCLC.
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [11] Restored microRNA-519a enhances the radiosensitivity of non-small cell lung cancer via suppressing EphA2
    Shulei Gong
    Yu Li
    Ling Lv
    Wanfu Men
    Gene Therapy, 2022, 29 : 588 - 600
  • [12] Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment
    Kim, Seok Min
    Lee, Soo Yun
    Kim, Seo In
    Bae, Ji Yeong
    Hong, Jin Tae
    Jo, Seona
    Kim, Ji Hyun
    Chung, Hyo-Young
    Kim, Tae-Don
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [13] Restored microRNA-519a enhances the radiosensitivity of non-small cell lung cancer via suppressing EphA2
    Gong, Shulei
    Li, Yu
    Lv, Ling
    Men, Wanfu
    GENE THERAPY, 2022, 29 (10-11) : 588 - 600
  • [14] Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
    Jose Carlini, Maria
    Roitman, Pablo
    Nunez, Myriam
    Guadalupe Pallotta, Maria
    Boggio, Gaston
    Smith, David
    Salatino, Mariana
    de Kier Joffe, Elisa D. Bal
    Rabinovich, Gabriel A.
    Puricelli, Lydia I.
    LUNG CANCER, 2014, 84 (01) : 73 - 78
  • [15] Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer
    Li, Ning
    Liu, Shaohui
    Sun, Mingjiao
    Chen, Wei
    Xu, Xiaogang
    Zeng, Zhu
    Tang, Yemin
    Dong, Yongquan
    Chang, Alex H.
    Zhao, Qiong
    TRANSLATIONAL ONCOLOGY, 2018, 11 (01): : 11 - 17
  • [16] Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma
    Ishikawa, Masashi
    Miyahara, Ryo
    Sonobe, Makoto
    Horiuchi, Marika
    Mennju, Toshi
    Nakayama, Ei
    Kobayashi, Masashi
    Kikuchi, Ryutaro
    Kitamura, Jiro
    Imamura, Naoto
    Huang, Cheng-Long
    Date, Hiroshi
    LUNG CANCER, 2012, 76 (03) : 431 - 438
  • [17] Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients with Non-Small Cell Lung Cancer
    Wang, Erjian
    Nickens, Dana J.
    Bello, Akintunde
    Khosravan, Reza
    Amantea, Michael
    Wilner, Keith D.
    Parivar, Kourosh
    Tan, Weiwei
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5722 - 5728
  • [18] Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients
    Osa, Akio
    Uenami, Takeshi
    Koyama, Shohei
    Fujimoto, Kosuke
    Okuzaki, Daisuke
    Takimoto, Takayuki
    Hirata, Haruhiko
    Yano, Yukihiro
    Yokota, Soichiro
    Kinehara, Yuhei
    Naito, Yujiro
    Otsuka, Tomoyuki
    Kanazu, Masaki
    Kuroyama, Muneyoshi
    Hamaguchi, Masanari
    Koba, Taro
    Futami, Yu
    Ishijima, Mikako
    Suga, Yasuhiko
    Akazawa, Yuki
    Machiyama, Hirotomo
    Iwahori, Kota
    Takamatsu, Hyota
    Nagatomo, Izumi
    Takeda, Yoshito
    Kida, Hiroshi
    Akbay, Esra A.
    Hammerman, Peter S.
    Wong, Kwok-Kin
    Dranoff, Glenn
    Mori, Masahide
    Kijima, Takashi
    Kumanogoh, Atsushi
    JCI INSIGHT, 2018, 3 (19):
  • [19] Clinical Upstaging of Non-Small Cell Lung Cancer That Extends Across the Fissure: Implications for Non-Small Cell Lung Cancer Staging
    Joshi, Vijay
    McShane, James
    Page, Richard
    Carr, Martyn
    Mediratta, Neeraj
    Shackcloth, Michael
    Poullis, Michael
    ANNALS OF THORACIC SURGERY, 2011, 91 (02): : 350 - 354
  • [20] EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
    Kaminskyy, Vitaliy O.
    Haag, Petra
    Novak, Metka
    Vegvari, Akos
    Arapi, Vasiliki
    Lewensohn, Rolf
    Viktorsson, Kristina
    CANCERS, 2021, 13 (05) : 1 - 23
12345